This site is intended for Healthcare Professionals only.

Tag: BGMA

spot_imgspot_img

Current VPAS rate is threat to billions of pound of NHS savings; BGMA proposes reform

The British Generic Manufacturers Association (BGMA) has published a positioning paper which sets out the objectives that need to be delivered through the next...

BGMA appoints Diane DiGangi Trench as its new vice-chair

The British Generic Manufacturers Association (BGMA) has elected Diane DiGangi Trench to be its new vice-chair. DiGangi Trench takes up the position replacing Xiromed’s Peter...

BGMA seeks judicial review on being excluded from VPAS negotiation

The British Generic Manufacturers Association (BGMA) has sought a judicial review of the Department of Health and Social Care’s (DHSC) decision to negotiate a new Voluntary...

High VPAS tax for 2023 risks more medicines shortages, says BGMA

The British Generic Manufacturers Association (BGMA) has raised concerns over the rise in the VPAS rate for 2023 to 26.5 per cent. The Department of...

BGMA calls for VPAS exemption for branded generics and biosimilars

The British Generic Medicines Association (BGMA) has called for exemption from the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), an agreement between...

BGMA backs move to analyse supply chain data to avoid overpricing of meds

The British Generic Manufacturers Association (BGMA) backs the government's decision to analyse quarterly sales and volume data from the whole supply chain, including manufacturers,...